Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
Authors:
Open Access
- 2 May 2022
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 20 (1) , 1-15
Abstract
Multidrug resistance is still a major obstacle to cancer treatment. The most studies are to inhibit the activity of the drug transporter P-glycoprotein (P-gp), but the effect is not ideal. Herein, a nanosystem was built based on cascade catalytic consumption of cholesterol. Cholesterol oxidase (natural enzyme, COD) was immobilized on the carrier (NH2-MIL-88B, MOF) through amide reaction, COD catalyzed the consumption of cholesterol, the reaction product H2O2 was further produced by the MOF with its peroxidase-like activity to produce hydroxyl radicals (•OH) with killing effect. Due to the high expression of CD44 receptor on the surface of tumor cells, we encapsulated chondroitin sulfate gel shell (CS-shell) with CD44 targeting and apoptosis promoting effect on the surface of DOX@MOF-COD nanoparticles, which can accurately and efficiently deliver the drugs to the tumor site and improve the effect of reversing drug resistance. Taking drug-resistant cell membrane as "breakthrough", this paper will provide a new idea for reversing multidrug resistance of tumor. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (No. 81971741)
This publication has 51 references indexed in Scilit:
- Doxorubicin‐Loaded Magnetic Silk Fibroin Nanoparticles for Targeted Therapy of Multidrug‐Resistant CancerAdvanced Materials, 2014
- Regulation of the cancer cell membrane lipid composition by NaCHOleateBiochimica et Biophysica Acta (BBA) - Biomembranes, 2014
- Nanopreparations to overcome multidrug resistance in cancerAdvanced Drug Delivery Reviews, 2013
- Epigenetic Modulation of the Biophysical Properties of Drug-Resistant Cell Lipids to Restore Drug Transport and Endocytic FunctionsMolecular Pharmaceutics, 2012
- Novel Route to Size-Controlled Fe–MIL-88B–NH2 Metal–Organic Framework NanocrystalsLangmuir, 2011
- Paclitaxel‐Loaded Polymer Nanoparticles for the Reversal of Multidrug Resistance in Breast Cancer CellsAdvanced Functional Materials, 2011
- Drug Resistance in Breast Cancer Cells: Biophysical Characterization of and Doxorubicin Interactions with Membrane LipidsMolecular Pharmaceutics, 2010
- Modulation of inflammation by chondroitin sulfateOsteoarthritis and Cartilage, 2010
- ABC transporters in cancer: more than just drug efflux pumpsNature Reviews Cancer, 2010
- Cholesterol oxidase: biotechnological applicationsThe FEBS Journal, 2009